Recommendation ID
CG117/3
Question
New entrant screening and treatment for latent tuberculosis (TB) infection:- A study is needed of people found by new entrant screening to be Mantoux positive and interferon-gamma positive, to establish better estimates of the cost effectiveness of screening and treatment for latent TB infection in this population. This could identify factors predisposing people to developing active TB so that more effective targeted treatment programmes can be developed for latent TB infection.
Any explanatory notes
(if applicable)
Why this is important:-The current guideline recommendations are based on a health economic model, which attempts to target effort on those people at highest risk. This would be more useful if more accurate cost-effectiveness estimates were available.

Source guidance details

Comes from guidance
Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control
Number
CG117
Date issued
March 2011

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No